Consensus guideline for the management of gastric cancer with synchronous peritoneal metastases
Cancer · 2025
DOI: 10.1002/cncr.35870 ↗Kurz gefasst
Leitlinie in der Zeitschrift Cancer, 2025. Verfasst von Samuel D Butensky und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, Department of Surgery, Yale University, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Stomach Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: NCI NIH HHS, Irving Harris Foundation.
Abstract (Originalsprache)
Background
Gastric cancer with synchronous peritoneal metastases is a debilitating disease with limited treatment options. This article describes an update of the 2018 Chicago Consensus guidelines addressing the management of gastric cancer with synchronous peritoneal metastases in line with the most recent evidence.
Methods
A clinical management pathway was updated through two rounds of a Delphi consensus to assess agreement levels with pathway blocks. Supporting evidence underwent evaluation using a rapid literature review. Meta‐analyses were performed as appropriate.
Results
Overall, the level of evidence in this disease subset was low to moderate. Of 124 participants in the first round, 109 (88%) responded in the second round. Strong consensus (>90%) was achieved in six of eight blocks (75%) in rounds 1 and 2. A multidisciplinary preoperative assessment and diagnostic laparoscopy should be offered to all patients, whereas patients with a high burden of disease or progression should undergo nonsurgical management. Patients with stable/responsive disease and a low peritoneal carcinomatosis index should subsequently be offered treatment with regional therapeutic interventions and cytoreductive surgery. In patients who are cytology‐positive, systemic therapy can be used to convert them to cytology‐negative, with subsequent surgery offered according to the patient's goals of care. Meta‐analysis of observational and randomized control trials revealed a survival benefit with the addition of intraperitoneal chemotherapy to cytoreductive surgery (hazard ratio, 0.52).
Conclusions
The consensus‐driven clinical pathway for gastric cancer with synchronous peritoneal metastases offers vital clinical guidance for practitioners. There is a growing body of high‐quality evidence to support management strategies, and future clinical trials are eagerly awaited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Surgical Oncology, Department of Surgery, Yale University, New Haven, Connecticut, USA.
- City of Hope National Medical Center, Duarte, California, USA.
- Mercy Medical Center, Baltimore, Maryland, USA.
- Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- Department of Surgery, The Pennsylvania State University, Hershey, Pennsylvania, USA.
- Johns Hopkins University, Baltimore, Maryland, USA.
ORCID-Profile: Samuel D Butensky, Varun V Bansal, David G Su, Jorge L Gomez-Mayorga, Shannon N Radomski, Kiran K Turaga, Brian D Badgwell, Harry H Yoon
Förderung
- NCI NIH HHS
- Irving Harris Foundation
Zitieren
APA
Butensky, S. D., Bansal, V. V., Su, D. G., Waheed, M. T., Nikiforchin, A., Gomez-Mayorga, J. L., Olecki, E., Radomski, S. N., Sun, B., Turaga, K. K., Gunderson, C. G., Lacy, J., Badgwell, B. D., In, H., Kennedy, T., Yoon, H. H., Greer, J. B., Sundar, R., Woo, Y., & Peritoneal Surface Malignancies Consortium Group (2025). Consensus guideline for the management of gastric cancer with synchronous peritoneal metastases. Cancer. https://doi.org/10.1002/cncr.35870
Vancouver
Butensky SD, Bansal VV, Su DG, Waheed MT, Nikiforchin A, Gomez-Mayorga JL, et al. Consensus guideline for the management of gastric cancer with synchronous peritoneal metastases. Cancer. 2025. doi:10.1002/cncr.35870
BibTeX
@article{Butensky2025,
author = {Butensky, Samuel D and Bansal, Varun V and Su, David G and Waheed, Muhammad Talha and Nikiforchin, Andrei and Gomez-Mayorga, Jorge L and Olecki, Elizabeth and Radomski, Shannon N and Sun, Beatrice and Turaga, Kiran K and Gunderson, Craig G and Lacy, Jill and Badgwell, Brian D and In, Haejin and Kennedy, Timothy and Yoon, Harry H and Greer, Jonathan B and Sundar, Raghav and Woo, Yanghee and Peritoneal Surface Malignancies Consortium Group, Peritoneal Surface Malignancies Consortium Group},
title = {Consensus guideline for the management of gastric cancer with synchronous peritoneal metastases},
journal = {Cancer},
year = {2025},
doi = {10.1002/cncr.35870}
}
EUVIMED